Stocks · News reference
Novo Nordisk to Present New Semaglutide Clinical Data at The Liver Meeting 2026
Novo Nordisk announced it will present 12 new abstracts featuring real-world and clinical data on semaglutide at the American Association for the Study of Liver Diseases (AASLD) congress in November 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Sofie Mørck Jarl appointed new CFO at Copenhagen Airports A/S
Copenhagen Airports A/S has appointed Sofie Mørck Jarl as its new CFO, effective no later than 1 March 2027. Jarl joins from Novo where she served as Group Vice President for Finance & Business Support, and previously worked as CFO at Novo Nordisk Engineering A/S. She succeeds Rasmus Lund, who passed away in July. The CEO praised her extensive financial and strategic expertise, particularly her experience managing major investments and complex projects.
Sofie Mørck Jarl bliver ny CFO i Københavns Lufthavne A/S
Copenhagen Airports A/S has appointed Sofie Mørck Jarl as its new CFO, effective March 1, 2027. She joins from Novo Nordisk where she served as Group Vice President for Finance & Business Support, bringing experience in financial leadership, strategy, and major investment management. She replaces Rasmus Lund, who passed away unexpectedly in July.